comparemela.com

Leonard Post News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Rakovina Therapeutics Announces Strategic Pivot to AI

Rakovina Therapeutics Inc. , ("Rakovina" or the "Company"), a biopharmaceutical company dedicated to improving the lives of cancer patients through the development of novel DNA-damage response inhibitor therapeutics, is pleased to announce a.

United kingdomBritish columbiaUnited statesDavid hymanDennis brownArtem cherkasovJeffrey bachaPetra hamerlikHwang shenVancouver prostate centreDrug administrationRegulation services providerRakovina therapeutics incCompany scientific advisory boardUniversity of british columbiaHealth canada

Rakovina Therapeutics Announces Strategic Pivot to AI

Company Leveraging Deep Docking AI Drug Discovery PlatformVANCOUVER, British Columbia, March 27, 2024 Rakovina Therapeutics Inc. , , a biopharmaceutical company dedicated to improving the lives.

British columbiaUnited kingdomUnited statesHwang shenDavid hymanPetra hamerlikDennis brownArtem cherkasovJeffrey bachaRegulation services providerDrug administrationHealth canadaRakovina therapeutics incUniversity of british columbiaCompany scientific advisory boardVancouver prostate centre

Fulgent Genetics, Inc (FLGT) Q2 2022 Earnings Call Transcript

FLGT earnings call for the period ending June 30, 2022.

New yorkUnited statesPaul kimNicole borsjeMichael nohailePiper sandlerPatty murphyLarry weissBrandon perthuisDave westenberg piper sandlerDavid westenbergMing hsiehGina wallarExchange commissionFulgent genetics incYork city health

Fulgent Genetics, Inc (FLGT) CEO Ming Hsieh on Q2 2022 Results - Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:NASDAQ:FLGT) Q2 2022 Results Earnings Conference Call August 4, 2022, 04:30 PM ET Company Participants Nicole Borsje - Investor Relations, The Blueshirt Group.

New yorkUnited statesPaul kimNicole borsjeMichael nohaileLawrence weissPiper sandlerPatty murphyLarry weissBrandon perthuisDavid westenbergMing hsiehGina wallarCompany participantsBlueshirt groupExchange commission

Fulgent Genetics Welcomes Dr Michael Nohaile and Dr Leonard Post to Board of Directors

Fulgent Genetics Welcomes Dr. Michael Nohaile and Dr. Leonard Post to Board of Directors - read this article along with other careers information, tips and advice on BioSpace

United statesMichael nohaileMing hsiehUniversity of californiaDevelopment for onyx pharmaceuticalsMassachusetts institute of technologyBiomarin pharmaceutical incUniversity of michiganExchange commissionUniversity of wisconsinFulgent genetics incAmgen incMckinsey companyDiscovery research for parke davis pharmaceuticalsChief scientific officerGenerate biomedicines

vimarsana © 2020. All Rights Reserved.